Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05883449
What this trial is testing

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma
Affimed GmbH 25
Early research (Phase 1)WithdrawnNCT03782363
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Italian Sarcoma Group
Early research (Phase 1)Looking for participantsNCT06138587
What this trial is testing

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaLeukemiaLeukemia, Myeloid+3 more
Dana-Farber Cancer Institute 15
Not applicableNo Longer AvailableNCT05131438
What this trial is testing

An Expanded Access Program to Provide Sugemalimab for the Treatment of Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (R/R ENKTL)

Who this might be right for
Extranodal NK/T-cell Lymphoma
EQRx International, Inc.
Testing effectiveness (Phase 2)UnknownNCT01178658
What this trial is testing

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Seoul National University Hospital 42
Early research (Phase 1)Not Yet RecruitingNCT07518654
What this trial is testing

Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma

Who this might be right for
Leukaemia (Acute Lymphoblastic)Leukaemia (Acute Myeloid)Neuroblastoma+7 more
Michel Duval 12
Testing effectiveness (Phase 2)UnknownNCT03439501
What this trial is testing

Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Samsung Medical Center 21
Testing effectiveness (Phase 2)Ended earlyNCT02465957
What this trial is testing

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Who this might be right for
Stage IIIB Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma
ImmunityBio, Inc. 7
Testing effectiveness (Phase 2)UnknownNCT01592422
What this trial is testing

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 60
Testing effectiveness (Phase 2)UnknownNCT02507154
What this trial is testing

Reactivating NK Cells in Treating Refractory Head and Neck Cancer

Who this might be right for
Nasopharyngeal CancerHead and Neck Squamous Cell Carcinoma
National University Hospital, Singapore 31
Not applicableStudy completedNCT00073229
What this trial is testing

Immune Function of Infants With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)UnknownNCT02734524
What this trial is testing

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Southwest Hospital, China 104
Testing effectiveness (Phase 2)Ended earlyNCT02533323
What this trial is testing

P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT02722668
What this trial is testing

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia/Lymphoma+22 more
Masonic Cancer Center, University of Minnesota 15
Early research (Phase 1)Study completedNCT03524235
What this trial is testing

Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

Who this might be right for
Multiple MyelomaCLLChronic Lymphocytic Leukemia+2 more
Noah Merin 20
Testing effectiveness (Phase 2)Ended earlyNCT01944982
What this trial is testing

Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

Who this might be right for
Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 7
Not applicableUnknownNCT02602574
What this trial is testing

ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?

Who this might be right for
Post-ERCP Acute Pancreatitis
University Hospital Rijeka 66
Testing effectiveness (Phase 2)Looking for participantsNCT07589530
What this trial is testing

Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid TumorsTROP2-Expressing Solid Tumors
Beijing Biotech 60
Not applicableStudy completedNCT03063723
What this trial is testing

Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C (Disorder)
Third Affiliated Hospital, Sun Yat-Sen University 25
Testing effectiveness (Phase 2)UnknownNCT02030561
What this trial is testing

NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer

Who this might be right for
Breast CancerGastric Cancer
National University Hospital, Singapore 29
Next Page